PROSTATILEN LYOPHILISATE FOR INJECTION AMPOULES 5 MG

PHARMACOLOGICAL PROPERTIES:

Pharmacodynamics. Prostatilen has a specific organotropic effect on the prostate gland. In diseases of the latter, the drug as a means of pathogenetic therapy normalizes the processes of microcirculation and platelet vascular hemostasis, reduces and eliminates tissue swelling, leukocyte infiltration (including reducing the content of leukocytes in the gland secretion), exhibits an indirect bacteriostatic effect on the secretion microflora, reduces the titer of the identified pathogen up to absolute sterility or inhibits the vital activity of microorganisms. Prostatilen normalizes spermatogenesis (increases the number and motility of spermatozoa), has a modulating effect on the state of T-and B-lymphocytes, regulates bladder muscle tone, including the tone of the detrusor, increases the nonspecific resistance of the organism.
Pharmacokinetics. As a peptide drug, prostatilen is cleaved by cellular proteases to amino acids. Prostatilen and its metabolites are excreted in the urine. The drug does not have a cumulative effect.

INDICATIONS:

chronic prostatitis, prostate adenoma, age-related dysfunctions of the prostate gland and related urinary disorders, complications after operations on the prostate gland; with interoreceptive copulative dysfunction; male infertility

APPLICATION:

for the treatment of adult men, including the elderly. Enter in the / m. Before use, the contents of the ampoule are dissolved in 1–2 ml of water for injection or isotonic p-ra sodium chloride, or 0.5% p-ra Novocaine (procaine). The drug is administered daily, 1–2 ampoules 1 time per day. The course of treatment is 5-10 days. If necessary, repeat the course (after 1-6 months).

CONTRAINDICATIONS:

hypersensitivity to the components of the drug and proteins of cattle.

SIDE EFFECTS:

allergic reactions are possible.

SPECIAL INSTRUCTIONS:

when using novocaine (procaine) as a solvent, it is necessary to conduct a skin allergy test.When treating with a drug, it is recommended to conduct a clinical analysis of indicators of prostate gland activity (prostate-specific antigen).
The ability to influence the reaction rate when driving or working with other mechanisms. Not investigated.

INTERACTIONS:

did not study.

OVERDOSE:

was not studied.

STORAGE CONDITIONS:

in a dark place at a temperature of no higher than 20 ° C.